Smith & Nephew plc

UNDERVALUEDSNNUF · OTC · Healthcare
SNNUF·OTC·Healthcare
UNDERVALUED
Smith & Nephew plc
12.3%upside
MARKET PRICE
$15.55
FAIR PRICE
$17.46
MARGIN
$1.91
UNDERVALUEDFAIROVERVALUED
P/E RATIO
13.0x
DIV. YIELD
4.00%
ROE
19.6%
MARKET CAP
$13B
FPI
fairpriceindex.com

FAIR PRICE VALUATION

12.3%upside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$15.55

FAIR PRICE

$17.46

MARGIN

$1.91

UNDERVALUEDFAIROVERVALUED

P/E Ratio

13.0x

What is P/E? →

Div. Yield

4.00%

ROE

19.6%

Strong

Market Cap

$13B

Large-cap

NOW AVAILABLE

Get notified when SNNUF's fair price changes

Push notifications when SNNUF's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

6.5/ 10

Attractive valuation, but limited growth momentum.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$13.97CONSERVATIVE ENTRY
$17.46FAIR PRICE
$15.55MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$13.97

Fair price × 0.80

DISTANCE

10.2%

Price to entry level

At the current price of $15.55, SNNUF trades 10.2% above the conservative entry level of $13.97. This entry level represents a 20% margin of safety below the calculated fair price of $17.46 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate SNNUF's fair price

Smith & Nephew plc's fair price of $17.46 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $15.55, SNNUF trades 12.3% below its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting SNNUF's risk profile.

RELATIVE · 30%

Comparing SNNUF's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for SNNUF, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate SNNUF's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for SNNUF.

Explore on Bulios

FAQ

What is the fair price of SNNUF?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Smith & Nephew plc is $17.46. At the current market price of $15.55, SNNUF trades 12.3% below its calculated fair value.

Is SNNUF overvalued or undervalued?+

Smith & Nephew plc is currently undervalued based on our valuation model. The stock trades at $15.55, which is 12.3% below the fair price of $17.46. The P/E ratio of 13.0x is a key metric in the valuation.

What is the margin of safety for SNNUF?+

With a 20% margin of safety applied to the fair price of $17.46, the conservative entry level for SNNUF is $13.97. At the current market price of $15.55, the stock trades 10.2% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is SNNUF's fair price updated?+

We update fair price calculations for SNNUF daily after market close. The current fair price of $17.46 incorporates the latest market data and sector multiples.

What factors affect SNNUF's fair price calculation?+

SNNUF's fair price of $17.46 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 13.0x, ROE of 19.6%, and dividend yield of 4.00%.

Is SNNUF a good buy right now?+

At $15.55, SNNUF trades 12.3% below our fair value estimate of $17.46. The stock is currently undervalued. ROE stands at 19.6% (strong). Fair Price Index provides valuation data — always do your own research before investing.

Does SNNUF pay dividends?+

SNNUF has a dividend yield of 4.00%.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.